What are the latest figures on the iron deficiency anemia market’s size and projected CAGR?
The iron deficiency anemia market size has grown strongly in recent years. It will grow from $3.37 billion in 2024 to $3.58 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to initiatives by non-government organizations, rising cases of chronic disorders, increasing focus on parental care, awareness campaigns targeting nutritional deficiency, and expansion of telemedicine.
The iron deficiency anemia market size is expected to see strong growth in the next few years. It will grow to $4.55 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to increasing focus on women’s health, growing demand for minimally invasive therapies, availability of over-the-counter products, expansion of distribution networks, and rising adoption of personalized medicine. Major trends in the forecast period include the development of an innovative drug delivery system, advancements in diagnostic tools, advancements in monitoring devices, the development of combination therapies, and the integration of nanotechnology in drug delivery.
Get Your Free Sample of The Global Iron Deficiency Anemia Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21212&type=smp
Which Market drivers have played a significant role in driving the iron deficiency anemia market?
The increasing cases of nutritional deficiencies are expected to propel the iron deficiency anemia market going forward. Nutritional deficiency refers to a condition that occurs when the body lacks the necessary amount of one or more essential nutrients, such as vitamins, minerals, proteins, or fats, required for optimal health. Nutritional deficiencies are on the rise due to poor dietary choices, with the widespread consumption of processed foods and food insecurity, which limits access to nutrient-dense options in lower-income populations. Iron deficiency anemia is a common form of nutritional deficiency where a lack of iron in the diet leads to a decrease in the number of red blood cells, impairing the body’s ability to transport oxygen. For instance, in December 2023, according to National Health Services, a UK-based government department, the total hospital admissions in the United Kingdom for nutritional deficiency in 2021/22 accounted for 250,000, which doubled in 2022/23 and reached 500,000. Therefore, the increasing cases of nutritional deficiencies drive the iron deficiency anemia market.
What are the key segments within the iron deficiency anemia market?
The iron deficiency anemia market covered in this report is segmented –
1) By Therapy Type: Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion
2) By Distribution Channel: Hospital Pharmacy, Drug Stores and Retail Pharmacies, Online Pharmacies
3) By End Users: Hospitals, Clinics, Home Healthcare
Subsegments:
1) By Oral Iron Therapy: Ferrous Sulfate, Ferrous Gluconate, Ferrous Fumarate, Polysaccharide-Iron Complex, Carbonyl Iron
2) By Parenteral Iron Therapy: Iron Sucrose, Ferric Carboxymaltose, Iron Dextran, Ferumoxytol, Ferric Gluconate
3) By Red Blood Cell Transfusion: Leukocyte-Reduced Red Blood Cell Transfusion, Washed Red Blood Cell Transfusion, Irradiated Red Blood Cell Transfusion
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/iron-deficiency-anemia-global-market-report
Which key players are shaping the iron deficiency anemia market?
Major companies operating in the iron deficiency anemia market are AbbVie Inc., Sanofi S.A., Abbott Laboratories, Fresenius SE & Co. KGaA, Sandoz International GmbH, CSL Limited, Daiichi Sankyo Company Limited, Perrigo Company, Cipla Limited, Dr. Reddy’s Laboratories Limited, Cadila Healthcare Limited, Zydus Cadila, Lupin Limited, Alkem Laboratories Limited, AMAG Pharmaceuticals Inc., Akebia Therapeutics Inc., Rockwell Medical Inc., Pharmacosmos A/S, Shield Therapeutics plc, AdvaCare Pharma LLC
Which transformative trends will shape the iron deficiency anemia market landscape?
Major companies operating in the iron deficiency anemia market are focusing on developing innovative solutions, such as intravenous iron injection, to provide a precise combination of nutrients that maximize absorption and enhance tolerance, effectively addressing iron deficiency. Intravenous iron injection is a medical procedure used to deliver iron directly into the bloodstream to treat iron deficiency or anemia when oral supplements are ineffective or insufficient. For instance, in March 2024, Cadila Pharmaceuticals, an India-based pharmaceutical company, launched Redshot FCM, an intravenous iron injection formulated with ferric carboxymaltose to effectively treat iron deficiency anemia (IDA). This innovative product is suitable for both adults and children over one year old who cannot tolerate oral iron supplements. With a strong safety profile and minimal risk of anaphylaxis, Redshot FCM allows for the administration of high doses of iron in a single session, facilitating rapid improvement in hemoglobin levels. It is especially beneficial for vulnerable groups such as pregnant women, the elderly, and cancer patients.
How do regional factors impact the iron deficiency anemia market, and which region is the largest contributor?
North America was the largest region in the iron deficiency anemia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the iron deficiency anemia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Iron Deficiency Anemia Market Report 2025 Offer?
The iron deficiency anemia market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Iron deficiency anemia is a condition in which the body lacks enough iron to produce an adequate amount of hemoglobin, a protein in red blood cells that carries oxygen throughout the body. Iron deficiency can occur due to insufficient dietary intake, poor absorption of iron, blood loss, or increased iron needs (such as during pregnancy).
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21212
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
